What would happen if drug price 'negotiation' brought down pharma list prices across the board? Not much at all, at least not for...

New research by David Cuttler with McKinsey and Partners published in JAMA shows that there are $250B in healthcare savings annually....

From NYC to Texas, the feeling going into this Memorial Day weekend is that we're finally done with COVID. But is the virus done with us?

The drug-price watchdog ICER just issued a "Report on Unsupported Price Increases". The 'study' made the headlines, but it is problematic.

Thanks to the team at PharmaVoice for the interview for the "Year in Preview" issue. My two cents on multi-stakeholder commercial models.